Clinical trial
Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With…
NCT00312195 · Purdue Pharma LP, Industry · Completed
Key facts
| NCT number | NCT00312195 |
|---|---|
| Title | Safety and Efficacy of Buprenorphine Transdermal System (BTDS) in Subjects With Chronic Nonmalignant Pain |
| Official title | An Open-label Run-in, Followed by a Randomized, Double-blind, Placebo Controlled, Parallel Group Study to Show the Effectiveness of Buprenorphine Transdermal System in Management of Patients With Chronic Nonmalignant Pain Syndromes |
| Lead sponsor | Purdue Pharma LP, Industry |
| Collaborators | Napp Pharmaceuticals Limited Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Non-malignant Pain |
| Intervention type | Drug |
| Interventions | Buprenorphine transdermal patch, Placebo to match BTDS |
| Enrollment | 267 |
| Start date | Mar 1, 2001 |
| Primary completion | Jul 1, 2001 |
| Completion | Jul 1, 2001 |
| First posted | Apr 7, 2006 |
| Last update posted | Sep 10, 2012 |
| Countries | United Kingdom, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: